Jeffery and his colleagues defined an anaemic event as the drop of Hb to less than 10 g/dl, the use of blood transfusion or EPO therapy, whereas CIA in our study was defined as patients who develop anaemia from normal Hb or had worsening severity of anaemia post-chemotherapy (8). The gene discussed is GSTM1; the disease is anemia.